Product Information

ALYQ 20 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1448 per EA under NDC 00480927706. Its NADAC has been published 139 times since Mar 20, 2024.

FDA first approved this application on Oct 12, 2022. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the Tadalafil market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ALYQ 20 MG TABLET

Tadalafil
$0.1448per EA
Low Outlier

Strength

20 mg/1

NDC

00480927706

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

TADALAFIL

Approval Type

Generic (ANDA)

FDA Application

ANDA216932

FDA Approved

10/12/2022

TE Code

AB2

On Market Since

2/20/2024

Pharmacological Classes

Phosphodiesterase 5 Inhibitor
Phosphodiesterase 5 Inhibitors

Price Statistics

The NADAC for ALYQ 20 MG TABLET has been published 139 times since Mar 20, 2024, and over the history we have for it it has declined 68.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1448 per EA
All-time high$0.4527 (Apr 10, 2024)
All-time low$0.1330 (Jul 22, 2026)
52-week high$0.1803
52-week low$0.1330
Median price$0.2161
Average price$0.2224
Largest weekly change+41.0% (Aug 21, 2024)
Weeks tracked139
Tracking sinceMar 20, 2024

Price History

1W

0.0%

1M

-1.0%

3M

+8.9%

6M

-9.9%

1Y

-28.9%

3Y

N/A

5Y

N/A

All

-68.0%

Generic Alternatives

The matcher finds 18 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ALYQ 20 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ALYQ 20 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.1448 per EA (NDC 00480927706), effective Nov 11, 2026.

How has the price of ALYQ 20 MG TABLET changed over time?

Over the history we have for it, the NADAC for ALYQ 20 MG TABLET has declined 68.0%. It has been tracked across 139 weekly CMS publications since Mar 20, 2024.

What are the highest and lowest recorded NADAC prices for ALYQ 20 MG TABLET?

Since Mar 20, 2024, the NADAC for ALYQ 20 MG TABLET has ranged from a low of $0.1330 (Jul 22, 2026) to a high of $0.4527 (Apr 10, 2024), with a median of $0.2161 per EA.

Are there cheaper alternatives to ALYQ 20 MG TABLET?

18 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ALYQ 20 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ALYQ 20 MG TABLET?

ALYQ 20 MG TABLET (NDC 00480927706) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.